Surgical instrument tracking and sterile processing software for hospitals
Censis Technologies builds cloud software for tracking surgical instruments and endoscopes across sterile processing and the OR, on a Microsoft-centric stack of C#/.NET and SQL Server with a Vue/TypeScript front end. Power BI and Microsoft Fabric sit alongside a product roadmap shifting toward predictive analytics, while support-weighted hiring and recurring installation and defect themes point to heavy on-site implementation work.
Notable leadership hires: Director Product Management
Censis Technologies, founded in 2001 and headquartered in Franklin, Tennessee, makes surgical instrument inventory management software for hospitals. Its products cover the perioperative loop, including instrument tracking, loaner management, endoscope reprocessing and instrument marking, with CensiTrac as a core product. The privately held company employs 51–200 people and hires in the United States. Customer support runs on Zendesk and Salesforce Service Cloud, and integrations use Boomi.
Censis uses C#, .NET, SQL Server and MySQL on the back end, Vue, TypeScript and Vite on the front end, AWS for hosting, Boomi for integration, and Power BI with Microsoft Fabric for analytics.
Job posts point to a product roadmap shifting toward predictive analytics, Censis product suite implementations at client sites, hardware installation during operational readiness validations, and software upgrade training.
Censis Technologies is headquartered in Franklin, Tennessee, and currently hires in the United States across support, engineering, product and sales.
Other companies in the same industry, closest in size
Censis Technologies, Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.